Anturol

Active Ingredient(s): Oxybutynin
FDA Approved: * December 7, 2011
Pharm Company: * ANTARES PHARMA INC
Category: Urinary System

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Anturol Overview

Oxybutynin (brand names Ditropan, Lyrinel XL, Lenditro (ZA), Driptane (RU), Uripan (Middle East)[1]) is an anticholinergic medication used to relieve urinary and bladder difficulties, including frequent urination and inability to control urination (urge incontinence), by decreasing muscle spasms of the bladder.[2] It is also given to help with symptoms associated with kidney stones. It competitively antagonizes the M1, M2, and M3 subtypes of the muscarinic acet...

Read more Anturol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Oxybutynin

Recent Anturol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Oxybutynin
  • Film, Extended Release: 2.6mg, 3.9mg/24hr
  • Gel: 10%, 10% (100mg/packet), 10%(100mg/packet), 3%
  • Gel, Metered: 3%
  • Syrup: 5mg/5ml
  • System: 3.9mg
  • Tablet: 5mg
  • Tablet, Extended Release: 10mg, 15mg, 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Oxybutynin or a similar ingredient: (6 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 12 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA